Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) Short Interest Update

Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) was the target of a large growth in short interest in December. As of December 31st, there was short interest totalling 2,400 shares, a growth of 20.0% from the December 15th total of 2,000 shares. Based on an average daily volume of 15,700 shares, the days-to-cover ratio is currently 0.2 days.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Tema Cardiovascular and Metabolics ETF stock. Sterling Investment Advisors Ltd. grew its position in shares of Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) by 3.7% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 158,695 shares of the company’s stock after buying an additional 5,605 shares during the quarter. Tema Cardiovascular and Metabolics ETF accounts for 1.4% of Sterling Investment Advisors Ltd.’s portfolio, making the stock its 23rd largest position. Sterling Investment Advisors Ltd. owned about 6.40% of Tema Cardiovascular and Metabolics ETF worth $5,332,000 at the end of the most recent quarter.

Tema Cardiovascular and Metabolics ETF Stock Performance

Shares of NASDAQ HRTS traded down $0.19 during midday trading on Friday, hitting $28.70. 10,235 shares of the company traded hands, compared to its average volume of 12,749. Tema Cardiovascular and Metabolics ETF has a 12-month low of $28.56 and a 12-month high of $36.03. The firm has a market cap of $66.30 million, a P/E ratio of 32.89 and a beta of 0.93. The stock has a 50-day moving average price of $30.62 and a 200 day moving average price of $32.85.

Tema Cardiovascular and Metabolics ETF Dividend Announcement

The company also recently announced a dividend, which was paid on Thursday, December 12th. Stockholders of record on Wednesday, December 11th were given a $0.4693 dividend. The ex-dividend date of this dividend was Wednesday, December 11th.

About Tema Cardiovascular and Metabolics ETF

The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive.